Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Mucosis B.V.
DescriptionBroad spectrum pneumococcal vaccine based on mimopath technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPneumococcus
Indication DetailsPrevent pneumococcal infections
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today